UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
for the quarterly period ended September 30, 2020
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
for the transition period from ___ to ___
Commission file number 000-55728
AMERICAN REBEL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
|
|
Nevada | 47-3892903 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
718 Thompson Lane, Suite 108-199, Nashville, Tennessee | 37204 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (833) 267-3235 |
Copies of communications to: |
Anthony N. DeMint, Esq. DeMint Law, PLLC 3753 Howard Hughes Parkway Second Floor, Suite 314 Las Vegas, Nevada 89169 (702) 714-0889 |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ ] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ] | Accelerated filer [ ] |
Non-accelerated filer [X] | Smaller reporting company [X] |
| Emerging growth company [X] |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes [ ] No [X]
The number of shares of the registrant’s common stock outstanding as of November 6, 2020 was 69,697,250 shares.
1
AMERICAN REBEL HOLDINGS, INC.
INDEX TO QUARTERLY REPORT ON FORM 10-Q
|
|
|
PART I. FINANCIAL INFORMATION | Page No. | |
|
|
|
Item 1. | Interim Condensed Consolidated Financial Statements (unaudited) | 3 |
|
|
|
| Consolidated Condensed Balance Sheets of American Rebel Holdings, Inc. at September 30, 2020 (unaudited) and December 31, 2019 (audited) | 3 |
|
|
|
| Consolidated Condensed Statements of Operations of American Rebel Holdings, Inc. for the three months ended September 30, 2020 and 2019 (unaudited) | 4 |
|
|
|
| Consolidated Condensed Statements of Operations of American Rebel Holdings, Inc. for the nine months ended September 30, 2020 and 2019 (unaudited) | 5 |
|
|
|
| Consolidated Condensed Statements of Stockholders Deficit of American Rebel Holdings, Inc. for the nine months ended September 30, 2020 and 2019 (unaudited) | 6 |
|
|
|
| Consolidated Condensed Statements of Cash Flows of American Rebel Holdings, Inc. for the nine months ended September 30, 2020 and 2019 (unaudited) | 7 |
|
|
|
| Notes to the Financial Statements (unaudited) | 8 |
|
|
|
Item 2. | Management’s Discussion and Analysis | 19 |
|
|
|
Item 3. | Quantitative and Qualitative Disclosures about Market Risk. | 22 |
|
|
|
Item 4. | Controls and Procedures | 22 |
|
|
|
PART II. OTHER INFORMATION |
| |
|
|
|
Item 1. | Legal Proceedings | 23 |
|
|
|
Item 1A. | Risk Factors | 23 |
|
|
|
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 23 |
|
|
|
Item 3. | Defaults upon Senior Securities | 24 |
|
|
|
Item 4. | Mine Safety Disclosure | 24 |
|
|
|
Item 5. | Other Information | 24 |
|
|
|
Item 6. | Exhibits | 24 |
|
|
|
Signatures |
| 26 |
2
Part I. Financial Information
Item 1.- Interim Consolidated Financial Statements (unaudited)
AMERICAN REBEL HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
| September 30, 2020 (unaudited) |
| December 31, 2019 (audited) |
ASSETS |
|
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
Cash and cash equivalents | $ | 165,881 | $ | 131,656 |
Accounts Receivable |
| 276,961 |
| 228,890 |
Prepaid expense |
| 101,248 |
| 542,800 |
Inventory |
| 823,943 |
| 805,845 |
Inventory deposits |
| 6,488 |
| 91,641 |
Total Current Assets |
| 1,374,521 |
| 1,800,832 |
|
|
|
|
|
Property and Equipment, net |
| 20,469 |
| 66,990 |
|
|
|
|
|
OTHER ASSETS: |
|
|
|
|
Lease Deposit |
| 6,841 |
| 6,841 |
Total Other Assets |
| 6,841 |
| 6,841 |
|
|
|
|
|
TOTAL ASSETS | $ | 1,401,831 | $ | 1,874,663 |
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) |
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
Accounts payable and accrued expense |
| 630,038 |
| 684,126 |
Accrued Interest – Convertible Debenture – Related Party |
| 602,002 |
| 303,860 |
Loan – Officer - Related party |
| 105,551 |
| 4,496 |
Loan – Working Capital, net of discounts of $597,025 and $147,823 |
| 4,181,678 |
| 3,595,561 |
Loans - Nonrelated parties |
| 15,649 |
| 25,746 |
Total Current Liabilities |
| 5,534,918 |
| 4,613,789 |
|
|
|
|
|
Convertible Debenture –Related party, net of discounts of $92,110 and $137,110 |
| 275,390 |
| 207,890 |
TOTAL LIABILITIES |
| 5,810,308 |
| 4,821,679 |
|
|
|
|
|
STOCKHOLDERS’ EQUITY (DEFICIT): |
|
|
|
|
Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued or outstanding |
| - |
| - |
Common stock, $0.001 par value; 100,000,000 shares authorized; 66,397,929 and 43,062,058 issued and outstanding, respectively at September 30, 2020 and December 31, 2019 |
| 66,398 |
| 43,062 |
Additional paid in capital |
| 15,016,419 |
| 11,899,553 |
Accumulated deficit |
| (19,491,294) |
| (14,889,631) |
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) |
| (4,408,477) |
| (2,947,016) |
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | $ | 1,401,831 | $ | 1,874,663 |
See Notes to Financial Statements.
3
AMERICAN REBEL HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
| For the three months ended September 30, 2020 (unaudited) |
| For the three months ended September 30, 2019 (unaudited) |
Revenue | $ | 279,308 | $ | 164,970 |
Cost of goods sold |
| 228,584 |
| 120,874 |
Gross margin |
| 50,724 |
| 44,096 |
|
|
|
|
|
Expenses: |
|
|
|
|
Consulting – business development |
| 136,877 |
| 3,168,335 |
Product development costs |
| 89,578 |
| 39,331 |
Marketing and brand development costs |
| 90,305 |
| 153,764 |
Administrative and other |
| 286,541 |
| 412,007 |
Depreciation expense |
| 15,507 |
| 15,507 |
|
| 618,808 |
| 3,788,944 |
Operating income (loss) |
| (568,084) |
| (3,744,848) |
|
|
|
|
|
Other Income (Expense) |
|
|
|
|
Interest expense |
| (681,076) |
| (424,346) |
Loss on extinguishment of debt |
| (68,925) |
| - |
Net income (loss) before income tax provision |
| (1,318,085) |
| (4,169,194) |
Provision for income tax |
| - |
| - |
Net income (loss) | $ | (1,318,085) | $ | (4,169,194) |
Basic and diluted income (loss) per share | $ | (0.02) | $ | (0.13) |
Weighted average common shares outstanding - basic and diluted |
| 64,346,000 |
| 31,167,000 |
|
|
|
|
|
See Notes to Financial Statements.
4
AMERICAN REBEL HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
|
|
|
| For the nine months ended September 30, 2020 (unaudited)
|
| For the nine months ended September 30, 2019 (unaudited)
|
Revenue | $ | 899,238 | $ | 294,032 |
Cost of goods sold |
| 659,006 |
| 192,104 |
Gross margin |
| 240,232 |
| 101,928 |
|
|
|
|
|
Expenses: |
|
|
|
|
Consulting – business development |
| 404,700 |
| 3,667,062 |
Product development costs |
| 275,565 |
| 263,298 |
Marketing and brand development costs |
| 331,775 |
| 508,235 |
Administrative and other |
| 1,356,430 |
| 640,250 |
Depreciation expense |
| 46,521 |
| 46,521 |
|
| 2,414,991 |
| 5,023,438 |
Operating income (loss) |
| (2,174,759) |
| (1,278,590) |
|
|
|
|
|
Other Income (Expense) |
|
|
|
|
Interest expense |
| (1,507,662) |
| (870,518) |
Loss on extinguishment of debt |
| (919,242) |
| - |
Net income (loss) before income tax provision |
| (4,601,663) |
| (5,893,956) |
Provision for income tax |
| - |
| - |
Net income (loss) | $ | (4,601,663) | $ | (5,893,956) |
Basic and diluted income (loss) per share | $ | (0.08) | $ | (0.19) |
Weighted average common shares outstanding - basic and diluted |
| 57,492,000 |
| 30,590,000 |
See Notes to Financial Statements.
5
AMERICAN REBEL HOLDINGS, INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT
|
|
|
|
|
|
|
|
|
|
| Common Stock |
| Common Stock Amount |
| Additional Paid-in Capital |
| Accumulated Deficit |
| Total |
|
|
|
|
|
|
|
|
| |
Balance – December 31, 2018 | 29,912,058 | $ | 29,912 | $ | 6,387,335 | $ | (7,287,559) | $ | (870,312) |
|
|
|
|
|
|
|
|
|
|
Common Stock issued as compensation | 400,000 |
| 400 |
| 232,100 |
| - |
| 232,500 |
|
|
|
|
|
|
|
|
|
|
Convertible Debenture Discount | - |
| - |
| 101,446 |
| - |
| 101,446 |
|
|
|
|
|
|
|
|
|
|
Net loss | - |
| - |
| - |
| (758,623) |
| (758,623) |
Balance – March 31, 2019 (Unaudited) | 30,312,058 | $ | 30,312 | $ | 6,720,881 | $ | (8,046,182) | $ | (1,294,989) |
|
|
|
|
|
|
|
|
|
|
Convertible Debenture Discount | - |
| - |
| 45,822 |
| - |
| 45,822 |
|
|
|
|
|
|
|
|
|
|
Net loss | - |
| - |
| - |
| (966,139) |
| (966,139) |
Balance – June 30, 2019 (unaudited) | 30,312,058 | $ | 30,312 | $ | 6,766,703 | $ | (9,012,321) | $ | (2,215,306) |
|
|
|
|
|
|
|
|
| |
Common Stock issued as compensation | 11,100,000 |
| 11,100 |
| 4,718,500 |
| - |
| 4,729,600 |
|
|
|
|
|
|
|
|
|
|
Net loss | - |
| - |
| - |
| (4,169,194) |
| (4,169,194) |
Balance – September 30, 2019-(Unaudited) | 41,412,58 | $ | 41.412 | $ | 11,485,303 | $ | (13,181,515) | $ | (1,654,900) |
| Common Stock |
| Common Stock Amount |
| Additional Paid-in Capital |
| Accumulated Deficit |
| Total |
|
|
|
|
|
|
|
|
|
|
Balance – December 31, 2019 | 43,062,058 | $ | 43,062 | $ | 11,899,553 | $ | (14,889,631) | $ | (2,947,016) |
|
|
|
|
|
|
|
|
|
|
Common Stock issued as compensation | 17,616,000 |
| 17,616 |
| 2,531,124 |
| - |
| 2,548,740 |
|
|
|
|
|
|
|
|
|
|
Net loss | - |
| - |
| - |
| (2,172,180) |
| (2,172,180) |
Balance – March 31, 2020 (Unaudited) | 60,678,058 | $ | 60,678 | $ | 14,430,677 | $ | (17,061,811) | $ | (2,570,456) |
Sale of Common Stock. | 70,000 |
| 70 |
| 6,930 |
| - |
| 7,000 |
Common Stock issued as compensation | 810,000 |
| 810 |
| 94,190 |
| - |
| 95,000 |
|
|
|
|
|
|
|
|
|
|
Net loss | - |
| - |
| - |
| (1,111,398) |
| (1,111,398) |
Balance – June 30, 2020 (Unaudited) | 61,558,058 | $ | 61,558 | $ | 14,531,797 | $ | (18,173,209) | $ | (3,579,854) |
Common Stock issued as compensation | 4,839,871 |
| 4,840 |
| 484,622 |
| - |
| 489,462 |
|
|
|
|
|
|
|
|
|
|
Net loss | - |
| - |
| - |
| (1,318,085) |
| (1,318,085) |
Balance – September 30, 2020 (Unaudited)- | 66,397,929 | $ | 66,398 | $ | 15,016,419 | $ | (19,491,294) | $ | (4,408,477) |
See Notes to Financial Statements.
6
AMERICAN REBEL HOLDINGS, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
|
|
|
|
|
|
| For the nine months ended September 30, 2020 (unaudited) |
| For the nine months ended September 30, 2019 (unaudited) |
|
|
|
|
|
CASH FLOW FROM OPERATING ACTIVITIES: |
|
|
|
|
Net income (loss) | $ | (4,601,663) | $ | (5,893,956) |
Depreciation |
| 46,521 |
| 46,521 |
Compensation paid through issuance of common stock |
| 2,142,868 |
| 3,322,000 |
Amortization of loan discount |
| 735,664 |
| 518,497 |
Adjustments to reconcile net loss to cash (used in) operating activities: |
|
|
|
|
Change in accounts receivable |
| (48,071) |
| (90,847) |
Change in prepaid expenses |
| 201,552 |
| 95,505 |
Change in inventory |
| (18,098) |
| (249,093) |
Change in inventory deposits |
| 85,153 |
| 229,180 |
Change in accounts payable and accrued expense |
| 244,054 |
| 313,482 |
Net Cash (Used in) Operating Activities |
| (1,212,020) |
| (1,708,711) |
|
|
|
|
|
CASH FLOW FROM INVESTING ACTIVITIES: |
|
|
|
|
Property and equipment purchased |
| - |
| - |
Net Cash (Used in) Operating Activities |
| - |
| - |
|
|
|
|
|
CASH FLOW FROM FINANCING ACTIVITIES: |
|
|
|
|
Proceeds (repayments) of loans – officer - related party |
| 101,055 |
| (12,092) |
Proceeds of sale of Common Stock |
| 7,000 |
| 1,000 |
Proceeds of Exercise of Warrants |
| - |
| 2,500 |
Proceeds of working capital loan |
| 2,208,671 |
| 2,524,875 |
Repayment of loans – nonrelated party |
| (1,070,481) |
| (642,756) |
Net Cash Provided by Financing Activities |
| 1,246,245 |
| 1,873,527 |
|
|
|
|
|
CHANGE IN CASH |
| 34,225 |
| 164,816 |
|
|
|
|
|
CASH AT BEGINNING OF PERIOD |
| 131,656 |
| 19,630 |
|
|
|
|
|
CASH AT END OF PERIOD | $ | 165,881 | $ | 184,446 |
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION |
|
|
|
|
Cash paid for: |
|
|
|
|
Interest | $ | 119,199 | $ | 77,860 |
Income taxes | $ | - | $ | - |
|
|
|
|
|
Non-cash investing and financing activities: |
|
|
|
|
Debt eliminated through issue of Common Stock | $ | 1,607,407 | $ | - |
|
|
|
|
|
See Notes to Financial Statements.
7
AMERICAN REBEL HOLDINGS, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2020
(unaudited)
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization
The “Company” was incorporated on December 15, 2014 (date of inception) under the laws of the State of Nevada, as CubeScape, Inc. Effective January 5, 2017, the Company amended its articles of incorporation and changed its name to American Rebel Holdings, Inc. The Company completed a business combination with its majority stockholder, American Rebel, Inc. on June 19, 2017. As a result, American Rebel, Inc. became a wholly owned subsidiary of the Company.
The acquisition of American Rebel, Inc. was accounted for as a reverse merger. The Company issued 17,421,000 shares of its common stock and issued warrants to purchase 500,000 shares of common stock to shareholders of American Rebel, Inc. and cancelled 9,000,000 shares of common stock owned by American Rebel, Inc.
The Company filed a registration statement on Form S-1 which was declared effective by the U.S. Securities and Exchange Commission on October 14, 2015. Twenty-six (26) investors invested at a price of $0.01 per share for a total of $60,000. The direct public offering closed on December 11, 2015.
Nature of operations
The Company is developing branded products in the safe and concealed carry/self-defense product areas that are promoted and sold wholesale through the company’s dealer network and direct to the consumer through the company’s website, Amazon.com, and others. The Company’s products will be under the American Rebel Brand and imprinted.
Interim Financial Statements and Basis of Presentation
The accompanying unaudited interim financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) set forth in Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by the U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These financial statements should be read along with the Annual Report filed on Form 10-K of the Company for the period ended December 31, 2019 and notes thereto contained.
Principles of Consolidation
The Consolidated Financial Statements include the accounts of the Company and its majority-owned subsidiary. All significant intercompany accounts and transactions have been eliminated.
Year end
The Company’s year-end is December 31.
Cash and cash equivalents
For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value.
Inventory and Inventory Deposits
Inventory consists of backpacks, jackets, safes and accessories manufactured to our design and held for resale and are carried at the lower of cost (First-in, First-out Method) or market value. The Company determines the estimate for the reserve for slow moving or obsolete inventories by regularly evaluating individual inventory levels, projected sales and current economic conditions. The Company also makes deposit payments on inventory to be manufactured that are carried separately until the goods are received into inventory.
8
Fixed assets and depreciation
Property and equipment is stated at cost net of accumulated depreciation. Additions and improvements are capitalized while ordinary maintenance and repair expenditures are charged to expense as incurred. Depreciation is recorded by the straight-line method over the estimated useful life of the asset, which ranges from five to seven years.
Revenue recognition
In accordance with ASC Topic 606, Revenue from Contracts with Customers ("ASC 606"), revenues are recognized when control of the promised goods or services is transferred to our clients, in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: 1) Identify the contract with a client; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to performance obligations in the contract; and (5) Recognize revenues when or as the company satisfies a performance obligation.
We adopted this ASC on January 1, 2018. Although the new revenue standard is expected to have an immaterial impact, if any, on our ongoing net income, we did implement changes to our processes related to revenue recognition and the control activities within them.
Advertising costs
Advertising costs are expensed as incurred; Marketing costs incurred were $90,305 and $153,764 for the three-month periods ended September 30, 2020 and 2019, respectively and $331,775 and $508,235, respectively, for the nine-month periods then ended.
Fair Value of Financial Instruments
Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2020 and December 31, 2019, respectively. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, and accounts payable. Fair values were assumed to approximate carrying values for cash and payables because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand.
Level 1: The preferred inputs to valuation efforts are “quoted prices in active markets for identical assets or liabilities,” with the caveat that the reporting entity must have access to that market. Information at this level is based on direct observations of transactions involving the same assets and liabilities, not assumptions, and thus offers superior reliability. However, relatively few items, especially physical assets, actually trade in active markets.
Level 2: FASB acknowledged that active markets for identical assets and liabilities are relatively uncommon and, even when they do exist, they may be too thin to provide reliable information. To deal with this shortage of direct data, the board provided a second level of inputs that can be applied in three situations.
Level 3: If inputs from levels 1 and 2 are not available, the Financial Accounting Standards Board (the “FASB”) acknowledges that fair value measures of many assets and liabilities are less precise. The board describes Level 3 inputs as “unobservable,” and limits their use by saying they “shall be used to measure fair value to the extent that observable inputs are not available.” This category allows “for situations in which there is little, if any, market activity for the asset or liability at the measurement date”. Earlier in the standard, FASB explains that “observable inputs” are gathered from sources other than the reporting company and that they are expected to reflect assumptions made by market participants.
Stock-based compensation
The Company records stock-based compensation in accordance with the guidance in ASC Topic 505 and 718 which requires the Company to recognize expense related to the fair value of its employee stock option awards. This eliminates accounting for share-based compensation transactions using the intrinsic value and requires instead that such transactions be accounted for using a fair-value-based method. The Company recognizes the cost of all share-based awards on a graded vesting basis over the vesting period of the award.
The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with FASB ASC 718-10 and the conclusions reached by the FASB ASC 505-50. Costs are measured at the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earliest of a performance commitment or completion of performance by the provider of goods or services as defined by FASB ASC 505-50.
9
In February 2020, the Company issued 1,200,000 shares of its Common Stock to pay professional and consulting fees. Total fair value of $240,000 was recorded as an expense of $85,000 at March 31, 2020 and prepaid expense of $155,000 for the remaining nine months of the consulting agreement. In June 2020, the Company issued 810,000 shares of its Common Stock to pay consulting fees and interest expense. Total fair value of $95,000 was recorded as an expense of $95,000 at June 30, 2020. In August 2020, the Company issued 4,839,871 shares of its Common Stock to pay consulting fees and interest expense. Total fair value of $489,462 was recorded as an expense of $489,462 at September 30, 2020.
Earnings per share
The Company follows ASC Topic 260 to account for earnings per share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.
Income taxes
The Company follows ASC Topic 740 for recording provision for income taxes. Deferred tax assets and liabilities are computed based upon the difference between the financial statement and income tax basis of assets and liabilities using the enacted marginal tax rate applicable when the related asset or liability is expected to be realized or settled. Deferred income tax expense or benefit is based on the changes in the asset or liability for each period. If available evidence suggests that it is more likely than not that some portion or the entire deferred tax asset will not be realized, a valuation allowance is required to reduce the deferred tax asset to the amount that is more likely than not to be realized. Future changes in such valuation allowance are included in the provision for deferred income tax in the period of change.
Deferred income tax may arise from temporary differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse.
The Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC Topic 740 only allows the recognition of tax benefits that have a greater than fifty percent likelihood of being sustained upon examination by taxing authorities. As of September 30, 2020 and December 31, 2019, the Company reviewed its tax positions and determined there were no outstanding, or retroactive tax positions with less than a 50% likelihood of being sustained upon examination by the taxing authorities, therefore this standard has not had a material effect on the Company.
The Company does not anticipate any significant changes to its total unrecognized tax benefits within the next 12 months.
The Company classifies tax-related penalties and net interest as income tax expense. For the nine month period ended September 30, 2020 and 2019, respectively, no income tax expense has been recorded.
Use of estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.
Recent pronouncements
The Company has implemented all new accounting pronouncements that are in effect and is evaluating any that may impact its financial statements. The Company does not believe that there are any new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.
10
NOTE 2 – GOING CONCERN
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. As noted above, the Company is in the development stage and, accordingly, our revenue from our planned operations does not cover our operating expenses. Since inception, the Company has been engaged in financing activities and executing its business plan of operations and incurring costs and expenses related to developing products and market identity, obtaining inventory and preparing for public product launch. As a result, the Company incurred net income (losses) for the nine months ended September 30, 2020 and 2019 of ($4,601,663) and ($5,893,956), respectively. The Company’s accumulated deficit was ($19,491,294) as of September 30, 2020 and ($14,889,631) as of December 31, 2019. The Company’s working capital deficit was ($4,160,397) as of September 30, 2020 and a deficit of ($2,812,957) as of December 31, 2019. In addition, the Company’s development activities since inception have been sustained through equity and debt financing and the deferral of payments on accounts payable and other expenses.
The ability of the Company to continue as a going concern is dependent upon its ability to raise capital from the sale of its equity and, ultimately, the achievement of operating revenues. Management believes holders of its warrants will execute their outstanding warrants generating investment capital for the Company. Management is also in discussion with several investment banks and broker dealers regarding the initiation of a capital campaign.
Management believes sufficient funding can be secured through the obtaining of loans, as well as future offerings of its preferred and common stock to institutional and other financial sources. However, no assurance can be given that the Company will obtain this additional working capital, or if obtained, that such funding will not cause substantial dilution to its stockholders. If the Company is unable to secure such additional funds from these sources, it may be forced to change or delay its business plan rollout.
These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.
Note 3- INVENTORY AND DEPOSITS
Inventory and deposits includes the following:
|
|
|
|
|
|
| |
|
| September 30, 2020 (unaudited) |
| December 31, 2019 (audited) | |||
|
|
|
|
|
|
| |
Inventory - Finished goods |
| $ | 823,943 |
| $ | 805,845 | |
Inventory deposits |
|
| 6,488 |
|
| 91,641 | |
|
|
| 830,431 |
|
| 897,486 | |
Less: Reserve for excess and obsolete |
|
| - |
|
| - | |
Net inventory and deposits |
| $ | 830,431 |
| $ | 897,486 | |
NOTE 4 – PROPERTY AND EQUIPMENT
Property and equipment includes the following: |
|
|
|
|
|
| |
|
| September 30, 2020 (unaudited) |
| December 31, 2019 (audited) | |||
|
|
|
|
|
|
| |
Marketing equipment |
| $ | 32,261 |
| $ | 32,261 | |
Vehicles |
|
| 277,886 |
|
| 277,886 | |
|
|
| 310,147 |
|
| 310,147 | |
Less: Accumulated depreciation |
|
| (289,678) |
|
| (243,157) | |
Net property and equipment |
| $ | 20,469 |
| $ | 66,990 | |
For the nine months ended September 30, 2020 and 2019 we recognized $46,521 and $46,521 in depreciation expense, respectively. We depreciate these assets over a period of sixty (60) months which has been deemed their useful life. In January 2016 we acquired three vehicles from related parties and assumed the debt secured by the vehicles as described at Note 6 – Notes Payable. Accordingly, the recorded cost of each vehicle is the amount of debt assumed under each related loan, or a total of $277,886.
11
NOTE 5 – RELATED PARTY NOTE PAYABLE AND RELATED PARTY TRANSACTIONS
For the year ended December 31, 2016, the Company received loans from its sole officer and director totaling $221,155. The balance at December 31, 2019 was $4,496. During the nine months ended September 30, 2020, the company repaid $0 of these loans resulting in a balance at September 30, 2020 of $4,496. During the nine months ended September 30, 2020, the Company received loans from an officer and director totaling $101,055. These loans are due on demand and carry no interest.
During the year ended December 31, 2018, the Company entered into several convertible debt instruments with stockholders in the amount of $270,000, for a total of $345,000. The Company accrued interest expense on this convertible debt of $30,966, for a total of $102,856 at September 30, 2020. Since public trading of the Company’s common stock began in 2018, the Company determined a Beneficial Conversion Discount of $270,000 applied to the 2018 sales the Convertible Debentures. The discount reduced the liability balance of the debentures to $0 when the debentures were issued and recorded the proceeds of the sale as Additional paid in Capital. The discount will be amortized over the three year term of the debentures. The discounted balance of the convertible debentures at September 30, 2020 was $275,390.
During the year ended December 31, 2018, holders of convertible debentures exercised their rights to convert the debt of $2,060,000 and accrued interest of $280,529 to 4,681,058 shares of common stock. Of the total amount borrowed under the convertible debt and exercise of warrants, $2,664,787 was loaned to American Rebel, Inc., the Company’s former majority stockholder and now the Company’s wholly owned subsidiary, as a working capital loan to pay its operating expenses including legal, accounting, product development, brand expansion, and marketing costs. This loan is eliminated in consolidation.
Charles A. Ross, Jr. serves as the Company’s CEO and Chairman of the Board of Directors. Compensation for Mr. Ross was $161,750 and $150,000, respectively for the nine months ended September 30, 2020 and 2019.
NOTE 6 – NOTES PAYABLE – NONRELATED PARTIES
Effective January 1, 2016, the Company acquired three vehicles from various related parties in exchange for the assumption of the liabilities related to those vehicles. The liabilities assumed are as follows at September 30, 2020 and December 31, 2019.
|
| September 30, |
| December 31, |
|
| 2020 |
| 2019 |
|
| (unaudited) |
| (audited) |
Loan secured by a tour bus, payable in monthly payments of $2,710 including interest at 12% per annum through June 2020. | $ | 15,649 | $ | 25,746 |
|
|
|
|
|
Total recorded as current liability | $ | 15,649 | $ | 25,746 |
Current and long-term portion. Total loan balance is reported as current because loans are past due, become due within one year or are expected to be repaid within one year.
NOTE 7 – NOTES PAYABLE – WORKING CAPITAL
During the nine months ended September 30, 2020, the Company and the Company’s wholly owned operating subsidiary completed the sale of additional short-term notes in the additional principal amount totaling $2,208,671. The notes are secured by a pledge of certain of the Company’s current inventory and the chief executive officer’s personal guaranty. These short-term working capital notes mature in 30-360 days. In connection with these notes, the Company issued 7,694,871 shares of its common stock. The fair value of these share incentives was calculated to be $893,652 The fair value of the share incentives was recorded as a discount to the notes payable and the discount was amortized over the term of those agreements to interest expense using the straight-line method that approximates the effective interest method. Interest expense recorded as a result of amortization of discount for the nine months ended September 30, 2020 is $735,664.
During the nine months ended September 30, 2020, the Company and the Company’s wholly-owned operating subsidiary completed the conversion of short term notes with a face value of $990,000 and accrued interest to 12,141,000 shares of Common Stock with a fair value of $1,753,140, resulting in a Loss on Extinguishment of Debt of $919,242.
As of September 30, 2020, and December 31, 2019, the outstanding balance due on the working capital notes was $4,778,703 and $3,595,561, respectively.
12
NOTE 8- CONVERTIBLE DEBENTURE – RELATED PARTY
Since September 16, 2016, the Company sold convertible debentures in the amount of $2,405,000 in the form of 12% three-year convertible term notes. Interest is accrued at an annual rate of 12% and is payable in common stock at maturity. Both principal and interest may be converted into common stock at a price of $0.50 per share after the passage of 181 days. The Company may redeem the debenture at its option or force conversion after common stock trades at a price in excess of $1.00 per share for five days. The Holder may force redemption after the Company raises $3 million dollars in equity. The holders of the convertible debentures were issued three-year warrants to purchase 2,405,000 shares of the Company’s common stock at $1.00 per share. As of December 31, 2019, the Company received $2,405,000 under this convertible debenture. In April and November, 2018, debentures with face value of $2,060,000 plus accrued interest of $280,529 were converted into 4,681,058 shares of common stock. As of December 31, 2019, the Company had a face value of $345,000 due under this convertible debenture.
The convertible debenture holder, based on its agreement, with maturities beginning September 16, 2019 has the option to convert their principal and interest into 690,000 (plus 164,424 for accrued interest) shares of common stock. The fair value of the embedded beneficial conversion feature resulted in a discount to the convertible debenture – related party of $137,110 at December 31, 2019 and a discount of $69,610 at September 30, 2020.
During the year ended December 31, 2018, the Company sold convertible debt instruments in the amount of $270,000. Since public trading of the Company’s common stock began in 2018, the Company determined a beneficial conversion discount of $270,000 applied to the 2018 sales the convertible debt instruments. The discount reduced the liability balance of the debentures to $0 when the debentures were issued and recorded the proceeds of the sale as Additional paid in Capital. The discount will be amortized over the three year term of the debentures. The discounted balance of the convertible debentures at September 30, 2020 was $275,390.
The Company analyzed the conversion option for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and fair value measurement under ASC 820 and determined that the beneficial conversion feature under the convertible debenture should be recorded as a discount to debt if market was more than the conversion feature.
The convertible debenture - related party is measured at fair value at the end of each reporting period or termination of the debenture agreement with the change in fair value recorded to earnings. The fair value of the embedded beneficial conversion feature did not result in a discount to the convertible debenture - related party. The discount if and when we have one will be amortized over the term of agreement or modification to the agreement to interest expense using the straight-line method that approximates the effective interest method.
The Company used the eight steps to determine fair value under ASC 820. (1) Identify the item to be valued and the unit of account. (2) Determine the principal or most advantageous market and the relevant market participants. (3) Select the valuation premise to be used for asset measurements. (4) Consider the risk assumptions applicable to liability measurements. (5) Identify available inputs. (6) Select the appropriate valuation technique(s). (7) Make the measurement. (8) Determine amounts to be recognized and information to be disclosed.
Fair value was determined by the market price of the Company’s publicly traded stock with no discount allowed. This was determined as of the effective date of the agreement entered convertible debenture - related party. The conversion price was then compared to fair value, determined by market price and the difference between the two multiplied by the number of shares that would be issued upon conversion. Since public trading of the common stock began in 2018, market price of the Company’s traded stock has ranged from $0.035 to $2.50 per share.
As of September 30, 2020, the outstanding balance due the convertible debentures holders was $345,000, including $0 in original issue discount or interest.
NOTE 9 – EMBEDDED DERIVATIVES – FINANCIAL INSTRUMENTS
Since September 2016 the Company entered into a financial instrument, which consists of a convertible debenture, containing a conversion feature. Generally financial instruments are convertible into shares of the Company’s common stock; at prices that are either marked to the volume weighted average price of the Company’s publicly traded stock or a static price determinative from each financial instrument agreement. These prices may be at a significant discount to market as determined overall by the volume weighted average price of the Company’s publicly traded common stock. The Company for all intent and purposes considers these discounts to be fair market value as would be determined in an arm’s length transaction with a willing buyer and the restrictive nature of the common stock issued, unless issued pursuant to a registration or some other registered shares with the SEC.
13
The Company accounts for the fair value of the conversion feature in accordance with ASC 815-15, Derivatives and Hedging; Embedded Derivatives, which requires the Company to bifurcate and separately account for the conversion features as an embedded derivative contained in the Company’s convertible debt and original issue discount notes payable. The Company is required to carry the embedded derivative on its balance sheet at fair value and account for any unrealized change in fair value as a component in its results of operations. The Company valued the embedded derivatives using eight steps to determine fair value under ASC 820. (1) Identify the item to be valued and the unit of account. (2) Determine the principal or most advantageous market and the relevant market participants. (3) Select the valuation premise to be used for asset measurements. (4) Consider the risk assumptions applicable to liability measurements. (5) Identify available inputs. (6) Select the appropriate valuation technique(s). (7) Make the measurement. (8) Determine amounts to be recognized and information to be disclosed.
The fair value of the conversion feature of the financial instrument as of September 30, 2020 was $0. The Company did not record any expense associated with the embedded derivatives at September 30, 2020. No embedded derivative expense was realized as there was no change in the conversion price.
NOTE 10 – INCOME TAXES
At September 30, 2020 and December 31, 2019, the Company had a net operating loss carryforward of $19,491,294 and $14,889,631, respectively, which begins to expire in 2034.
Components of net deferred tax asset, including a valuation allowance, are as follows:
|
| September 30, 2020 (unaudited) |
| December 31, 2019 (audited) | |
Deferred tax asset: |
|
|
|
| |
Net operating loss carryforward |
| $ | 4,093,171 | $ | 3,126,823 |
Total deferred tax asset |
|
| 4,093,171 |
| 3,126,823 |
Less: Valuation allowance |
|
| (4,093,171) |
| (3,126,823) |
Net deferred tax asset |
| $ | - | $ | - |
Valuation allowance for deferred tax assets as of September 30, 2020 and December 31, 2019 was $4,093,171 and $3,126,823, respectively. In assessing the recovery of the deferred tax asset, management considers whether it is more likely than not that some portion or the entire deferred tax asset will not be realized. The ultimate realization of the deferred tax asset is dependent upon the generation of future taxable income in the periods in which those temporary differences become deductible. Management considers the scheduled reversals of future deferred tax assets, projected future taxable income, and tax planning strategies in making this assessment. As a result, management determined it was more likely than not deferred tax assets will not be realized as of September 30, 2020 and December 31, 2019 and recognized 100% valuation allowance for each period.
Reconciliation between the statutory rate and the effective tax rate for both periods and as of December 31, 2019:
Federal statutory rate |
|
| (21.0) | % |
State taxes, net of federal benefit |
|
| (0.0) | % |
Change in valuation allowance |
|
| 21.0 | % |
Effective tax rate |
|
| 0.0 | % |
NOTE 11 – SHARE CAPITAL
The Company is authorized to issue 100,000,000 shares of its $0.001 par value common stock and 1,000,000 shares of its $0.001 par value preferred stock.
Common stock
During the nine months ended September 30, 2020, the Company issued 7,694,871 shares of its Common Stock in connection with issue of short-term loans. The fair value of these share incentives was calculated to be $893,652 which was recorded as a discount to the notes payable and amortized to interest expense over the term of those loan agreements. Interest expense recorded as a result of amortization of discount for the nine months ended September 30, 2020 is $735,664.
14
During the nine months ended September 30, 2020, the Company issued 10,641,000 shares of its Common Stock and completed the conversion of short-term notes with a face value of $900,000 and accrued interest. The fair value of these shares was calculated to be $1,581,240, resulting in a Loss on Extinguishment of Debt of $919,242.
In February 2020, the Company issued 1,200,000 shares of its Common Stock to pay professional and consulting fees. Total fair value of $240,000 was recorded as an expense of $205,000 at September 30, 2020 and prepaid expense of $35,000 for the remaining three months of the consulting agreement. In June 2020, the Company issued 810,000 shares of its Common Stock to pay consulting fees and interest expense. Total fair value of $95,000 was recorded as an expense of $95,000 at June 30, 2020
At September 30, 2020 and December 31, 2019, there were 66,397,929 and 43,062,058 shares of common stock issued and outstanding, respectively.
NOTE 12 – WARRANTS AND OPTIONS
In January 2019, the Company issued three-year and five-year warrants to purchase 75,000 shares of the Company’s common stock at $1.00 per share in conjunction with working capital loans totaling $75,000.
As of September 30, 2020, there were 2,320,000 warrants issued and outstanding. As of December 31, 2019, there were 2,320,000 warrants outstanding to acquire additional shares of common stock.
The Company evaluates outstanding warrants as derivative liabilities and will recognize any changes in the fair value through earnings. The Company determined that the Warrants have an immaterial fair value at September 30, 2020. The warrants do not trade in a highly active securities market, and as such, the Company estimated the fair value of these common stock equivalents using Black-Scholes and the following assumptions:
Expected volatility was based primarily on historical volatility. Historical volatility was computed using daily pricing observations for recent periods. The Company’s common stock has not traded so the volatility computation was based on other similarly situated companies. The Company believes this method produced an estimate that was representative of the Company’s expectations of future volatility over the expected term which due to their maturity period as expiry, it was three years. The Company had no reason to believe future volatility over the expected remaining life of these common stock equivalents was likely to differ materially from historical volatility. Expected life was based on three years due to the expiry of maturity. The risk-free rate was based on the U.S. Treasury rate that corresponded to the expected term of the common stock equivalents.
|
| September 30, 2020 (unaudited) |
| December 31, 2019 (audited) | |
|
|
|
|
| |
Stock Price |
| $ | .08 | $ | 0.285 |
Exercise Price |
| $ | 1.00 | $ | 1.00 |
Term (expected in years) |
|
| 3.00 |
| 3.00 |
Volatility |
|
| 259.2% |
| 262.4% |
Annual Rate of Dividends |
|
| 0.0% |
| 0.0% |
Risk Free Rate |
|
| 0.18% |
| 1.92% |
15
Stock Purchase Warrant
The following table summarizes all warrant activity for the year ended December 31, 2019 and the nine months ended September 30, 2020.
|
| Shares |
| Weighted-Average Exercise Price Per Share |
Remaining term |
Intrinsic value |
Outstanding, December 31, 2018 |
| 2,245,000 |
| $0.58 | .19 years | - |
Granted |
| 325,000 |
| $0.24 | .10 years | - |
Exercised |
| 250,000 |
| $0.01 | - | - |
Expired |
| - |
| - | - | - |
Outstanding and Exercisable at December 31, 2019 |
| 2,320,000 |
| $0.57 | 0.18 years | - |
|
|
|
|
|
|
|
Granted |
| - |
| - | - | - |
Exercised |
| - |
| - | - | - |
Expired |
| - |
| - | - | - |
Outstanding and Exercisable at September 30, 2020 |
| 2,320,000 |
| $0.57 | .18 years | - |
NOTE 13 – COMMITMENTS AND CONTINGENCIES
Rental Payments under Non-cancelable Operating Leases
The Company has a lease for warehouse and shipping space in Lenexa, Kansas which expires in January 2021. The following is a schedule, by year, of the future minimum rental payments under the lease:
Year ended December 31, |
|
|
|
|
|
2020 | $ | 121,992 |
2021 |
| 15,249 |
Total | $ | 137,241 |
Rent costs totaled approximately $106,086 and $74,930 for nine-month periods ended September 30, 2020 and 2019, respectively.
NOTE 14 – SUBSEQUENT EVENTS
The Company evaluated all events that occurred after the balance sheet date of September 30, 2020 through the date the financial statements were issued and determined that there were the following subsequent events:
Subsequent to September 30, 2020, the Company entered into a three-month promissory note with a lender dated October 1, 2020, for $250,000 at 8% interest.
Subsequent to September 30, 2020, the Company entered into a one-year note with a lender dated October 6, 2020, for $100,000 at 12% interest.
Subsequent to September 30, 2020, the Company refinanced an existing note into a one-year note with a lender dated October 13, 2020, for $200,000 at 12% interest.
Subsequent to September 30, 2020, the Company entered into a six-month promissory note with a lender dated October 21, 2020, for $250,000 at 8% interest.
16
FORWARD LOOKING STATEMENTS
This document contains “forward-looking statements”. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements or belief; and any statements of assumptions underlying any of the foregoing.
Forward-looking statements may include the words “may,” “could,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” or other similar words. These forward-looking statements present our estimates and assumptions only as of the date of this report. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. We do not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the dates they are made. You should, however, consult further disclosures we make in this Quarterly Report on Form 10-Q, Current Reports on Form 8-K and other reports made under the Exchange Act.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties. The factors impacting these risks and uncertainties include, but are not limited to:
·our ability to efficiently manage and repay our debt obligations;
·our inability to raise additional financing for working capital;
·our ability to generate sufficient revenue in our targeted markets to support operations;
·significant dilution resulting from our financing activities;
·actions and initiatives taken by both current and potential competitors;
·supply chain disruptions for components used in our products;
·manufacturers inability to deliver components or products on time;
·our ability to diversify our operations;
·the fact that our accounting policies and methods are fundamental to how we report our financial condition and results of operations, and they may require management to make estimates about matters that are inherently uncertain;
·adverse state or federal legislation or regulation that increases the costs of compliance, or adverse findings by a regulator with respect to existing operations;
·changes in U.S. GAAP or in the legal, regulatory and legislative environments in the markets in which we operate;
·deterioration in general or global economic, market and political conditions;
·inability to efficiently manage our operations;
·inability to achieve future operating results;
·the unavailability of funds for capital expenditures;
·our ability to recruit, hire and retain key employees;
·the impact of COVID-19 on the United States economy and our operations;
·the inability of management to effectively implement our strategies and business plans; and
·the other risks and uncertainties detailed in this report.
In this form 10-Q references to “American Rebel”, “the Company”, “we,” “us,” “our” and similar terms refer to American Rebel Holdings, Inc. and its wholly owned operating subsidiary, American Rebel, Inc.
17
COVID-19
The current and potential effects of coronavirus may impact our business, results of operations and financial condition.
Actual or threatened epidemics, pandemics, outbreaks, or other public health crises could materially and adversely impact or disrupt our operations, adversely affect the local economies where we operate and negatively impact our customers’ spending in the impacted regions or depending upon the severity, globally, which could materially and adversely impact our business, results of operations and financial condition. Fore example, since December 2019, a strain of novel coronavirus (causing “COVD-19”) surfaced in China and has spread into the United States, Europe and most other countries of the world, resulting in certain supply chain disruptions, volatilities in the tock market, lower oil and other commodity prices due to diminished demand, massive unemployment, and lockdown on international travels, all of which has had an adverse impact on the global economy. There is significant uncertainty around the breadth and duration of the business disruptions related to COVID-19, as well as its impact on the U.S. economy. Moreover, an epidemic, pandemic, outbreak or other public health crisis, such as COVID-19, could adversely affect our ability to adequately staff and manage our business. The extent to which COVID-19 impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain, rapidly changing and cannot be predicted, including new information that may emerge concerning the severity of COVID-19 and the actions taken to contain it or treat its impact.
18
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Management’s Discussion and Analysis should be read along with the financial statements included in this Quarterly Report on Form 10-Q (the “Financial Statements”). The Financial Statements have been prepared in accordance with generally accepted accounting policies in the United States (“GAAP”). Except as otherwise disclosed, all dollar figures included therein and in the following management discussion and analysis are quoted in United States dollars.
Operations
We are a company with limited financial resources. We have not established a firm source of equity or debt financing. Our independent registered public accounting firm has included an explanatory paragraph in their report filed on May 15, 2020 and included with our Form 10-K filed on May 15, 2020 emphasizing the uncertainty of our ability to remain as a going concern. An investor or financial statement reader should read our Risk Factors in full.
Description of Business
Company Overview
American Rebel is boldly positioning itself as America’s Patriotic Brand. The Company has identified the market opportunity to design, manufacture, and market innovative safes and concealed carry products. American Rebel accesses its market uniquely through its positioning as America’s Patriotic Brand, its wholesale dealer network, and the appeal of its products as well as through the profile and public persona of its founder and CEO, Andy Ross. Andy hosted his own television show for 12 years, has made multiple appearances over the years at trade shows, and is well-known in the archery world as the founder of Ross Archery, which was the world’s fastest growing bow company in 2007 and 2008. Andy has also released 3 CDs, done numerous radio and print interviews, and performed many concerts in front of thousands of people. Andy has the ability to present American Rebel to large numbers of potential customers through the appeal of his music and other supporting appearances. For example, his appearance on the History Channel hit show Counting Cars in February 2014 has been viewed by 2 million people or more. Bringing innovative products that satisfy an existing demand to the market through exciting means is the American Rebel blueprint for success.
From inception through September 30, 2020, we have generated an operating deficit of $19,491,294. We expect to incur additional losses during the fiscal year ending December 31, 2020 and beyond, principally as a result of our increased investment in inventory, marketing expenses due to product launch, and the initial limited sales of our new products as we seek to establish them in the marketplace.
Nine months Ended September 30, 2020 Compared To Nine months Ended September 30, 2019
Revenue and cost of goods sold
For the nine months ended September 30, 2020, we reported Sales of $899,238, compared to Sales of $294,032 for the nine months ended September 30, 2019. For the nine months ended September 30, 2020, we reported Cost of Sales of $659,006, compared to Cost of Sales of $192,104 for the nine months ended September 30, 2019. For the nine months ended September 30, 2020, we reported Gross Profit of $240,232, compared to Gross Profit of $101,928 for the nine months ended September 30, 2019. Sales of our products began during the fourth quarter of 2016.
Operating Expenses
Total operating expenses for the nine months ended September 30, 2020 were $2,414,991 compared to $5,125,366 for the nine months ended September 30, 2019 as further described below.
For the nine months ended September 30, 2020, we incurred consulting and business development expenses of $404,700, compared to consulting and business development expenses of $3,667,062 for the nine months ended September 30, 2019. The decrease in consulting and business development expenses is due to the increased reliance on the company’s internal systems.
For the nine months ended September 30, 2020, we incurred product development expenses of $275,565, compared to product development expenses of $263,298 for the nine months ended September 30, 2019. The small increase in product development expenses is due to the increase in new product development activities during the quarter.
19
For the nine months ended September 30, 2020, we incurred marketing and brand development expenses of $331,775, compared to marketing and brand development expenses of $508,235 for the nine months ended September 30, 2019. The decrease in marketing and brand development expenses relates to the company’s shift of capital to manufacture additional inventory.
For the nine months ended September 30, 2020, we incurred general and administrative expenses of $1,356,430, compared to general and administrative expenses of $640,250 for the nine months ended September 30, 2019. The increase relates primarily to an increase in professional, consulting and operating fees due to the acceleration in the expansion of our corporate structure and financing activities.
For the nine months ended September 30, 2020, we incurred depreciation expense of $46,521, compared to depreciation expense of $46,521 for the nine months ended September 30, 2019. The depreciation remaining constant is due to our use of straight-line depreciation.
For the nine months ended September 30, 2020, we incurred interest expense of $1,507,662, compared to interest expense of $870,518 for the nine months ended September 30, 2019. For the nine months ended September 30, 2020, we incurred a Loss on Extinguishment of Debt of $919,242, as we issued common shares to settle and reduce debt.
Net Loss
Net loss for the nine months ended September 30, 2020 amounted to $4,601,663, resulting in a loss per share of $0.08, compared to $5,893,956 for the nine months ended September 30, 2019, resulting in a loss per share of $0.19. The decrease in the net loss from the nine months ended September 30, 2019 to the nine months ended September 30, 2020 is primarily due to the company’s decrease in professional, consulting and operating fees after the acceleration in the expansion of our corporate structure and financing activities.
Three Months Ended September 30, 2020 Compared To Three Months Ended September 30, 2019
Revenue and cost of goods sold
For the three months ended September 30, 2020, we reported Sales of $279,308, compared to Sales of $164,970 for the three months ended September 30, 2019. For the three months ended September 30, 2020, we reported Cost of Sales of $228,584, compared to Cost of Sales of $120,874 for the three months ended September 30, 2019. For the three months ended September 30, 2020, we reported Gross Profit of $50,724, compared to Gross Profit of $44,096 for the three months ended September 30, 2019. Sales of our products began during the fourth quarter of 2016.
Operating Expenses
Total operating expenses for the three months ended September 30, 2020 were $618,808 compared to $3,788,944 for the three months ended September 30, 2019 as further described below.
For the three months ended September 30, 2020, we incurred consulting and business development expenses of $136,877, compared to consulting and business development expenses of $3,168,335 for the three months ended September 30, 2019. The decrease in consulting and business development expenses is due to the company’s increased reliance on its internal systems.
For the three months ended September 30, 2020, we incurred product development expenses of $89,578, compared to product development expenses of $39,331 for the three months ended September 30, 2019. The increase in product development expense is due to the increased activity of new product development during the quarter.
For the three months ended September 30, 2020, we incurred marketing and brand development expenses of $90,305, compared to marketing and brand development expenses of $153,764 for the three months ended September 30, 2019. The decrease in marketing and brand development expenses relates to the company’s shift of capital to manufacture additional inventory.
For the three months ended September 30, 2020, we incurred general and administrative expenses of $286,541, compared to general and administrative expenses of $412,007 for the three months ended September 30, 2019. The change relates primarily to a change in professional, consulting and operating fees due following the acceleration of the expansion of the corporate structure and financing activities.
For the three months ended September 30, 2020, we incurred depreciation expense of $15,507, compared to depreciation expense of $15,507 for the three months ended September 30, 2019. This amount remains constant due to our straight-line depreciation application.
20
Other income and expenses
For the three months ended September 30, 2020, we incurred interest expense of $681,076, compared to interest expense of $424,346 for the three months ended September 30, 2019. During the three months ended September 30, 2020, we recorded $273,592 in interest expense by amortization of the discount recorded for the issuance of shares of common stock in connection with working capital loans.
Net Loss
Net loss for the three months ended September 30, 2020 amounted to $1,318,085, resulting in a loss per share of $0.02, compared to $4,169,194 for the three months ended September 30, 2019, resulting in a loss per share of $0.13. The change in the net loss from the three months ended September 30, 2019 to the three months ended September 30, 2020 is primarily due to the reduction in corporate, consulting and financing costs.
Liquidity and Capital Resources
We are a development stage company and our revenue from our planned operations does not cover our operating expenses. We have a working capital deficit of $2,812,957 at December 31, 2019 and $4,160,397 at September 30, 2020 and have incurred a deficit of $19,491,294 from inception to September 30, 2020. We have funded operations primarily through the issuance of capital stock, convertible debt and other securities.
During the nine months ended September 30, 2020, we raised net cash of $7,000 by issuance of common shares, as compared to $0 for the nine months ended September 30, 2019. During the nine months ended September 30, 2020, we raised net cash of $125,000 through the issuance of a convertible promissory note, as compared to $0 for the nine months ended September 30, 2019. During the nine months ended September 30, 2020, we raised net cash of $2,208,671 through the issuance of notes payable secured by inventory, as compared to $2,524,875 for the nine months ended September 30, 2019. During the nine months ended September 30, 2020, we repaid $0 on loans received from our CEO, as compared to $0 that we repaid in loans from our CEO during the nine months ended September 30, 2019.
As we continue with the launch of our American Rebel safes and concealed carry product line we have devoted and expect to continue to devote significant resources in the areas of capital expenditures and marketing, sales, and operational expenditures.
We expect to require additional funds to further develop our business plan, including the anticipated launch of additional products in addition to continuing to market our safes and concealed carry product line. Since it is impossible to predict with certainty the timing and amount of funds required to establish profitability, we anticipate that we will need to raise additional funds through equity or debt offerings or otherwise in order to meet our expected future liquidity requirements. Any such financing that we undertake will likely be dilutive to existing stockholders.
In addition, we expect to also need additional funds to respond to business opportunities and challenges, including our ongoing operating expenses, protecting our intellectual property, developing or acquiring new lines of business and enhancing our operating infrastructure. While we may need to seek additional funding for such purposes, we may not be able to obtain financing on acceptable terms, or at all. In addition, the terms of our financings may be dilutive to, or otherwise adversely affect, holders of our common stock. We may also seek additional funds through arrangements with collaborators or other third parties. We may not be able to negotiate any such arrangements on acceptable terms, if at all. If we are unable to obtain additional funding on a timely basis, we may be required to curtail or terminate some or all of our product lines.
The preparation of financial statements and related footnotes requires us to make judgments, estimates, and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities.
An accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur periodically, could materially impact the financial statements.
Financial Reporting Release No. 60 requires all companies to include a discussion of critical accounting policies or methods used in the preparation of financial statements. There are no critical policies or decisions that rely on judgments that are based on assumptions about matters that are highly uncertain at the time the estimate is made. Note 1 to the financial statements, included elsewhere in this report, includes a summary of the significant accounting policies and methods used in the preparation of our financial statements.
21
Emerging Growth Company - We qualify as an “emerging growth company” under the recently enacted Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As a result, we are permitted to, and intend to, rely on exemptions from certain disclosure requirements. For so long as we are an emerging growth company, among other things, we will not be required to:
·Have an auditor report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;
·Submit certain executive compensation matters to shareholder advisory votes, such as “say-on-pay” and “say-on-frequency”
·Obtain shareholder approval of any golden parachute payments not previously approved; and
·Disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the Chief Executives compensation to median employee compensation.
In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period. Our financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards.
We will remain an “emerging growth company” until the earliest of (i) the last day of the first fiscal year in which our total annual gross revenues exceed $1 billion; (ii) the fifth anniversary of our first sale of common equity pursuant to an effective registration statement; (iii) the date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, which would occur if the market value of our ordinary shares that are held by non-affiliates exceeds $700 million as of the last business day of our most recently completed third fiscal quarter; or (iv) the date on which we have issued more than $1 billion in non-convertible debt during the preceding three-year period.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We are an emerging growth company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Principal Financial Officer, Charles A. Ross, Jr., evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this Report. Based on the evaluation, Mr. Ross concluded that our disclosure controls and procedures are effective in timely alerting him to material information relating to us required to be included in our periodic SEC filings. The Company hired a financial expert with the experience in creating and managing internal control systems as well to continue to improve the effectiveness of our internal controls and financial disclosure controls.
Changes in Internal Control over Financial Reporting
There has been no change in the Company’s internal controls over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.
Internal control systems, no matter how well designed and operated, have inherent limitations. Therefore, even a system which is determined to be effective cannot provide absolute assurance that all control issues have been detected or prevented. Our systems of internal controls are designed to provide reasonable assurance with respect to financial statement preparation and presentation.
22
Item 1 - Legal Proceedings
We know of no material, existing or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which our directors, officer or any affiliates, or any registered or beneficial stockholder, is an adverse party or has a material interest adverse to our interest.
Item 1a – Risk Factors
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item. However, we detailed significant business risks in Item 1A to our Form 10-K for the year ended December 31, 2019 filed on May 15, 2020, to which reference is made herein.
Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds
On July 3, 2020, the Company entered into a three-month loan agreement for $102,000, interest on the note will be 255,000 shares of common stock.
The Company entered into an amortized one-year promissory note on July 31, 2020, to a lender for $150,000 at 12% interest. A component of the note included 230,769 shares of common stock valued at $0.065. Additionally, the Company has issued 1,153,846 shares of common stock, valued at $0.065. Upon full repayment of the loan, 1,153,846 shares of common stock will be returned to the Company.
The Company entered into an amortized one-year promissory note on August 5, 2020, to a lender for $150,000 at 12% interest. A component of the note included 230,769 shares of common stock valued at $0.065. Additionally, the Company has issued 1,153,846 shares of common stock, valued at $0.065. Upon full repayment of the loan, 1,153,846 shares of common stock will be returned to the Company.
On September 30, 2020, the Company entered into an amortized one-year promissory note to a lender for $350,000 at 12% interest. A stipulation of this promissory note was that the Company pay in full the July 31, 2020, $150,000 promissory note. A component of the note included 1,458,333 shares of common stock valued at $0.035. Additionally, the Company has issued 1,605,475 shares of common stock, valued at $0.035. Upon full repayment of the loan, 1,605,475 shares will be returned to the Company.
Subsequent Issuances after Quarter-End
On October 1, 2020, the Company entered into a three-month promissory note with a lender for $250,000 at 8% interest. A component of the note is the issuance of 1,250,000 five-year warrants to purchase the Company’s common stock at $0.10 per share.
On October 6, 2020, the Company entered into a one-year note with a lender for $100,000 at 12% interest. A component of the note was the issuance of 1,000,000 shares of common stock of the Company valued at $0.10 per share.
On October 13, 2020, the Company refinanced an existing note into a one-year note with a lender for $200,000 at 12% interest. A component of the note was the issuance of 2,000,000 shares of common stock of the Company valued at $0.10 per share.
On October 13, 2020, the Company issued 300,000 shares of common stock of the Company valued at $0.10 per share as an interest payment on an outstanding note.
On October 21, 2020, the Company entered into a six-month promissory note with a lender for $250,000 at 8% interest. A component of the note is the issuance of 1,250,000 five-year warrants to purchase the Company’s common stock at $0.10 per share.
On November 5, 2020, the Company issued 310,000 shares of common stock of the Company valued at $0.10 per share as an interest payment on an outstanding note.
All of the above-described issuances were exempt from registration pursuant to Section 4(a)(2) and/or Regulation D of the Securities Act as transactions not involving a public offering. With respect to each transaction listed above, no general solicitation was made by either the Company or any person acting on its behalf. All such securities issued pursuant to such exemptions are restricted securities as defined in Rule 144(a)(3) promulgated under the Securities Act, appropriate legends have been placed on the documents evidencing the securities, and may not be offered or sold absent registration or pursuant to an exemption there from.
23
Issuer Purchases of Equity Securities
We did not repurchase any of our equity securities during the quarter ended September 30, 2020.
Item 3 – Defaults upon Senior Securities
We have entered into a number of promissory notes, some of which are in default as of September 30, 2020, or went into default before the filing of this Quarterly Report (See Note 7 to the financial statements).
Item 4 – Mine Safety Disclosures
Not applicable.
Item 5 – Other Information
None
Item 6 – Exhibits
American Rebel Holdings, Inc. includes by reference the following exhibits:
| 3.1* | Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to Form S-1, filed August 4, 2015) |
| 3.2* | Bylaws of CubeScape, Inc. (Incorporated by reference to Exhibit 3.2 to Form S-1, filed August 4, 2015) |
| Amended and Restated Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to Form 8-K, filed January 10, 2017) | |
| $250,000 Note (Incorporated by reference to Exhibit 4.1 to Form 8-K, filed July 12, 2017) | |
| $100,000 Note dated June 10, 2020 (Incorporated by reference to Exhibit 4.2 to Form 10-Q, filed August 14, 2020) | |
| $101,000 Note dated June 18, 2020 (Incorporated by reference to Exhibit 4.3 to Form 10-Q, filed August 14, 2020) | |
| 4.4 | $75,000 Note dated June 29, 2020 |
| $50,000 Note dated June 29, 2020 (Incorporated by reference to Exhibit 4.5 to Form 10-Q, filed August 14, 2020) | |
| $102,000 Note dated July 3, 2020 (Incorporated by reference to Exhibit 4.6 to Form 10-Q, filed August 14, 2020) | |
| $150,000 Note dated July 31, 2020 (Incorporated by reference to Exhibit 4.7 to Form 10-Q, filed August 14, 2020) | |
| $150,000 Note dated August 3, 2020 (Incorporated by reference to Exhibit 4.8 to Form 10-Q, filed August 14, 2020) | |
| 4.9# | $350,000 Labrys Promissory Note dated September 29, 2020 |
| 4.10# | $250,000 Note dated October 1, 2020 |
| 4.11# | $100,000 Note dated October 6, 2020 |
| 4.12# | $200,000 Note dated October 13, 2020 |
| 4.13# | $250,000 Note dated October 21, 2020 |
| 10.1* | Conflict of Interest Agreement (Incorporated by reference to Exhibit 10.2 to Form S-1, filed August 4, 2015) |
| Amended Stock Purchase and Reorganization Agreement (Incorporated by reference to Exhibit 10.3 to Form 8-K, filed June 22, 2017) | |
| Loan Agreement (Incorporated by reference to Exhibit 10.1 to Form 8-K, filed July 12, 2017) | |
| Security Agreement (Incorporated by reference to Exhibit 10.2 to Form 8-K, filed July 12, 2017) | |
| Guaranty (Incorporated by reference to Exhibit 10.3 to Form 8-K, filed July 12, 2017) | |
| $250,000 Working Capital Loan Agreement, Note, and Security Agreement dated June 29, 2018 (Incorporated by reference to Exhibit 10.6 to Form 10-Q, filed June 18, 2019) | |
| Notice of Amendment to June 29, 2018 Note (Incorporated by reference to Exhibit 10.7 to Form 10-Q, filed June 18, 2019) | |
| $50,000 Convertible Term Note dated October 2, 2018 (Incorporated by reference to Exhibit 10.8 to Form 10-Q, filed June 18, 2019) | |
| $100,000 Convertible Term Note dated October 5, 2018 (Incorporated by reference to Exhibit 10.9 to Form 10-Q, filed June 18, 2019) | |
| $400,000 Working Capital Loan Agreement and Note dated November 1, 2018 (Incorporated by reference to Exhibit 10.10 to Form 10-Q, filed June 18, 2019) | |
| $130,000 Loan and Security Agreement to invest in safe inventory dated January 2, 2019 (Incorporated by reference to Exhibit 10.11 to Form 10-Q, filed June 18, 2019) | |
| $55,000 Loan Agreement dated January 14, 2019 (Incorporated by reference to Exhibit 10.12 to Form 10-Q, filed June 18, 2019) |
24
| $25,000 Loan Agreement dated January 15, 2019 (Incorporated by reference to Exhibit 10.13 to Form 10-Q, filed June 18, 2019) | |
| $300,000 Loan Agreement dated January 22, 2019 (Incorporated by reference to Exhibit 10.14 to Form 10-Q, filed June 18, 2019) | |
| $150,000 Convertible Term Note dated March 1, 2019 (Incorporated by reference to Exhibit 10.15 to Form 10-Q, filed June 18, 2019) | |
| $125,000 Convertible Promissory Note dated February 15, 2020 (Incorporated by reference to Exhibit 10.16 to Form 10-Q, filed June 26, 2020) | |
| $90,000 Note dated February 18, 2020 (Incorporated by reference to Exhibit 10.17 to Form 10-Q, filed June 26, 2020) | |
| $180,000 Note dated February 20, 2020 (Incorporated by reference to Exhibit 10.18 to Form 10-Q, filed June 26, 2020) | |
| $200,000 Note dated March 6, 2020 (Incorporated by reference to Exhibit 10.19 to Form 10-Q, filed June 26, 2020) | |
| $722,422 Amortized Note dated March 10, 2020 (Incorporated by reference to Exhibit 10.20 to Form 10-Q, filed June 26, 2020) | |
| $90,000 Note dated March 11, 2020 (Incorporated by reference to Exhibit 10.21 to Form 10-Q, filed June 26, 2020) | |
| $300,000 Note dated March 26, 2020 (Incorporated by reference to Exhibit 10.22 to Form 10-Q, filed June 26, 2020) | |
| $100,000 Note dated May 20, 2020 (Incorporated by reference to Exhibit 10.23 to Form 10-Q, filed June 26, 2020) | |
| $75,000 Note dated June 29, 2020 (Incorporated by reference to Exhibit 10.24 to Form 10-Q, filed August 14, 2020) | |
| Labrys Fund $150,000 Securities Purchase Agreement (Incorporated by reference to Exhibit 10.25 to Form 10-Q, filed August 14, 2020) | |
| EMA Financial $150,000 Securities Purchase Agreement (Incorporated by reference to Exhibit 10.26 to Form 10-Q, filed August 14, 2020) | |
| Labrys Fund $350,000 Securities Purchase Agreement | |
| $250,000 Note dated October 1, 2020 | |
| $100,000 Note dated October 6, 2020 | |
| $200,000 Note dated October 13, 2020 | |
| $250,000 Note dated October 21, 2020 | |
| 31.1# | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 31.2# | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 32.1# | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
101.INS | XBRL Instance Document** | |
101.SCH | XBRL Taxonomy Extension Schema** | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase** | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase** | |
101.LAB | XBRL Taxonomy Extension Labels Linkbase** | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase** | |
* Filed with initial filing of the Company’s registration statement on Form S-1, August 4, 2015.
# Filed herewith.
** The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
25
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: November 16, 2020
AMERICAN REBEL HOLDINGS, INC.
(Registrant)
By: /s/ Charles A. Ross, Jr.
By: Charles A. Ross, Jr., President, CEO, Principal Executive Officer,
Treasurer, Chairman, CFO, Principal Financial Officer and Principal Accounting Officer
26
Exhibit 31.1 Certification by Chief Executive Officer
I, Charles A. Ross, Jr., certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of American Rebel Holdings, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 16, 2020
By: /s/ Charles A. Ross, Jr.
President, CEO, Principal Executive Officer,
Treasurer, Chairman, CFO, Principal Financial Officer
and Principal Accounting Officer
Exhibit 31.2
I, Charles A. Ross, Jr., certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of American Rebel Holdings, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 16, 2020
By: /s/ Charles A. Ross, Jr.
President, CEO, Principal Executive Officer,
Treasurer, Chairman, CFO, Principal Financial Officer
and Principal Accounting Officer
Exhibit 32.1 Certification by Chief Executive Officer
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of American Rebel Holdings, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Charles A. Ross, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
By: /s/ Charles A. Ross, Jr.
President, CEO, Principal Executive Officer,
Treasurer, Chairman, CFO, Principal Financial Officer
and Principal Accounting Officer
November 16, 2020
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code) and is not being filed as part of the Report or as a separate disclosure document.